Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Paclitaxel 100mg/16.7ml solution for infusion vials
0801050V0AAABAB
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paclitaxel 150mg/25ml solution for infusion vials
0801050V0AAACAC
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paclitaxel 300mg/50ml solution for infusion vials
0801050V0AAADAD
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paclitaxel 30mg/5ml solution for infusion vials
0801050V0AAAAAA
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paxene 100mg/16.7ml solution for infusion vials
0801050V0BCABAB
|
Paxene | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paxene 150mg/25ml solution for infusion vials
0801050V0BCACAC
|
Paxene | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paxene 300mg/50ml solution for infusion vials
0801050V0BCADAD
|
Paxene | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paxene 30mg/5ml solution for infusion vials
0801050V0BCAAAA
|
Paxene | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxol 100mg/16.7ml solution for infusion vials
0801050V0BBABAB
|
Taxol | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxol 150mg/25ml solution for infusion vials
0801050V0BBADAC
|
Taxol | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxol 300mg/50ml solution for infusion vials
0801050V0BBACAD
|
Taxol | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Taxol 30mg/5ml solution for infusion vials
0801050V0BBAAAA
|
Taxol | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.